Protonix iv and Community-acquired pneumonia - from FDA reports

Community-acquired pneumonia is reported only by a few people who take Protonix Iv. We study 33 people who have side effects while taking Protonix iv from FDA. Among them, 3 have Community-acquired pneumonia. Find out below who they are, when they have Community-acquired pneumonia and more.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Sep, 24, 2018

33 people reported to have side effects when taking Protonix iv.
Among them, 3 people (9.09%) have Community-acquired pneumonia

Number of reports submitted per year:

Could Protonix iv cause Community-acquired pneumonia?

Gender of people who have Community-acquired pneumonia when taking Protonix iv *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Community-acquired pneumonia when taking Protonix iv *:

Top co-used drugs for these people *:

  1. Unasyn: 3 people, 100.00%
  2. Reglan: 3 people, 100.00%
  3. Morphine: 3 people, 100.00%
  4. Levaquin: 3 people, 100.00%
  5. Ibuprofen: 3 people, 100.00%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Neuroleptic Malignant Syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents): 3 people, 100.00%
  2. Road Traffic Accident: 2 people, 66.67%
  3. Quadriplegia (a four limb paralysis): 2 people, 66.67%
  4. Rib Fracture: 1 person, 33.33%
  5. Fever: 1 person, 33.33%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

Do you have Community-acquired pneumonia while taking Protonix iv?

You are not alone:

Related studies

Protonix iv

Protonix iv has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. (latest outcomes from Protonix iv 64 users)

Community-acquired pneumonia

Community-acquired pneumonia (pneumonia by contact in community) has been reported by people with rheumatoid arthritis, multiple myeloma, high blood pressure, multiple sclerosis, primary pulmonary hypertension (latest reports from 230,913 Community-acquired pneumonia patients).

Drugs that are associated with Community-acquired pneumonia
Community-acquired pneumonia (2,916 drugs)
Could your condition cause Community-acquired pneumonia
Community-acquired pneumonia (3,842 conditions)
Protonix iv side effects
Browse all side effects of Protonix iv
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Protonix iv and have Community-acquired pneumonia

Recent updates

General studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.